Oral Tirzepatide
US$ 26.39
glp-1 drugs tablets Oral Orforglipron Is Approved for Obesity GLP-1 Weight Loss Treatment |
Description
Phoenixin 14 acutely inhibits ghrelin-stimulated food intake and activates glucose-responsive neurons in the hypothalamus in mice
Retatrutide at 28.3% in 80 weeks is producing pharmacologically what surgery produces anatomically, and doing so with a side-effect profile that serious adverse events comparable to placebo (4% in both arms)
This gives them a number of injectable and oral GLP-1 candidates, which are expected to begin clinical trials soon
Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease
Requires urgent reperfusion therapy (PCI or thrombolysis)
